
Explore the pharmaceutical ecosystem of innovators, healthcare professionals, patients, payers, and regulators, and learn how to align strategies across stakeholders to optimize access and patient care.
Pharma marketing relies on rigorous science and evidence, navigates strict regulation, and balances ethics with multistakeholder needs, including HCPs, payers, and patients, to safeguard welfare and trust.
Trace pharmaceutical marketing's metamorphosis from rep-driven, physician-centric outreach to a digital, omnichannel, patient-centric, data-driven ecosystem powered by artificial intelligence and real-world data.
The covid-19 catalyst forces pharma to reinvent engagement with a digital-first, omnichannel approach, blending virtual detailing, webinars, telehealth patient support, and data-driven insights.
Navigate global pharmaceutical advertising rules, including truthfulness, fair balance, and audience-specific standards across US, EU, and Japan, with DTCA, unbranded disease awareness, and HCP promotion aligned to Pi and SmPC.
Explore how pharmaceutical firms apply international and national ethical codes through self-regulation, ensuring transparent interactions with healthcare professionals, responsible event sponsorship, and ethical speaker engagements.
Build the pillars of ethical pharmaceutical marketing through robust internal compliance and MLR review. Emphasizes the compliance function, SOPs, training, monitoring, and leadership tone at the top.
Navigate pharmaceutical hcp relationships under strict regulatory compliance, embracing transparency through Sunshine Act and Open Payments Program, FIA disclosure, and independent medical education to protect patient benefit.
Uncover how to conduct rigorous market and competitive analysis in pharma, quantify addressable migraine markets, map competitors, identify unmet needs, and shape strategic decisions for Microblock's phase three trials.
Learn how segmentation, targeting, and positioning guide focused pharmaceutical marketing, identifying patient and physician segments, choosing a targeting strategy, and crafting tailored value propositions for payers and clinicians.
Architect a pharmaceutical marketing plan and mix that integrates the four Ps across the lifecycle. Set smart objectives, budgets, timelines, and KPIs to drive cross-departmental action.
Gilead launched sofosbuvir-based Sovaldi and Harvoni through precise segmentation, targeting, and positioning. They paired value demonstration, payer negotiations, patient support, and intensive HCP education to cure hepatitis C.
Embrace digital transformation to reshape pharma engagement through omnichannel online channels. Leverage websites, portals, email, SEO/SEM, webinars, mHealth apps, and patient portals to improve reach, relevance, and outcomes.
Explore value-driven content marketing, strategic social media use, and interactive e-detailing in pharma, with strict compliance and omnichannel integration for engaging HCPs and patients.
Harness crm, marketing automation, and digital analytics to power personalized, measurable pharmaceutical engagement with healthcare professionals, as Precision Pharma uses Veeva CRM, Salesforce Marketing Cloud, and Adobe Analytics for Oncotarget.
The Unwearable collection uses fashion-inspired visuals to raise GPP awareness and empathy, with patient collaboration and a digital-first, non-promotional strategy across channels.
Explore how truly integrated omnichannel marketing replaces fragmented multi-channel approaches to deliver seamless, personalized experiences for HCPs and patients across online and offline touchpoints.
Map health care professionals and patient journeys to uncover touchpoints, pain points, and moments of truth, then personalize across an omnichannel strategy using behavioral data and AI.
Learn how to build a seamless pharmaceutical omnichannel engine by integrating online and offline channels with a unified tech stack—CRM, CDP, CMS/DAM, AI, and APIs—driving personalized HCP and patient experiences.
Transform pharmaceutical marketing by partnering with time-constrained, digitally connected HCPs, delivering evidence-based, personalized value through independent CME, MSL support, and non-promotional tools.
Learn how pharma teams identify and ethically engage key opinion leaders and deploy medical science liaisons to foster non-promotional, science-driven partnerships that advance patient care.
Strategically evaluate and optimize HCP interaction channels—from in-person visits and medical congresses to digital channels—and implement robust measurement and a continuous improvement cycle to boost engagement.
Novo Nordisk advances diabetes care through unbiased, evidence-based education for healthcare professionals, delivering CME/IM, symposia, digital resources, and peer-led training aligned with ADA and EASD guidelines to improve patient outcomes.
Explore how patient centricity transforms pharma culture and compliant communication, from empathetic patient journeys to unbranded campaigns, shared decision making, and robust patient support programs.
Design holistic patient support programs to improve adherence, empower patients, and integrate AI personalization, real-world data, and health equity into brand strategy with strict compliance.
Explore ethical partnerships with patient advocacy groups to amplify the patient voice, gain deep patient insights, and co-create education, awareness, and trial materials while maintaining independence.
UCB's Embrace Epilepsy program offers holistic patient support beyond medication, including a digital hub, self-management tools, education, and collaboration with patient groups to reduce stigma and improve quality of life.
Navigate how market access secures reimbursement, appropriate pricing, and formulary listing by engaging payers and HTA bodies early, using value dossiers and real-world evidence to reach patients.
Explore health technology assessment and pharmacoeconomics, showing how cost effectiveness, cost utility (QALYs), and budget impact analyses plus patient reported outcomes build a value story for payers and HTA bodies.
Align pricing, reimbursement, and marketing to maximize patient access for high-cost therapies. Apply value-based pricing and innovative payment models through tightly integrated market access and marketing.
Novartis navigates Zolgensma access for SMA with proactive payer engagement and robust value dossiers. Offerings include outcomes-based agreements, installment payments, and early diagnosis via newborn screening to maximize patient access.
Master pharmaceutical marketing by learning how modern brands are researched, positioned, launched and optimized across the United States and Europe. This intermediate, practice-oriented course connects pharmaceutical marketing strategy with compliance, market access, HCP and patient engagement, omnichannel execution, real-world evidence, analytics, generative AI and agentic AI.
You will not simply watch theory. You will examine current 2026 issues, use practical frameworks, enter six decision-based role plays and complete an integrated global specialty launch capstone. The objective is to help you think like a pharmaceutical brand leader: commercially ambitious, evidence-driven, patient-centred and able to operate within regulatory, ethical and privacy guardrails.
WHY THIS COURSE IS DIFFERENT
Pharmaceutical marketing sits at the intersection of science, business, regulation and patient outcomes. A strong decision must create value for patients, healthcare professionals, payers and health systems while remaining credible to medical, legal, regulatory, privacy and market access teams.
This course therefore integrates the whole operating model. You will connect segmentation and positioning with evidence generation, promotional compliance, channel design, budget choices, launch sequencing and measurement. Downloadable toolkits, contemporary cases, quizzes, role plays and the final capstone turn the frameworks into professional decisions.
WHAT YOU WILL LEARN
- Build a compliant pharmaceutical marketing plan for US and European markets.
- Map the pharmaceutical ecosystem and align HCPs, patients, payers, providers, regulators and internal teams.
- Apply competitive analysis, segmentation, targeting, positioning, the pharmaceutical marketing mix, product lifecycle planning and brand strategy.
- Design omnichannel customer journeys across personal and non-personal channels, content, CRM, social media, e-detailing and next-best-action approaches.
- Create patient-centric initiatives that support education, access, adherence and responsible engagement.
- Link marketing strategy with market access, value demonstration, HTA, real-world evidence and HEOR.
- Evaluate generative and agentic AI use cases while addressing governance, transparency, privacy and human oversight.
- Define KPIs, interpret analytics and make better portfolio, launch and investment decisions.
CURRENT 2026 CASES AND ISSUES
The course includes updated learning materials on:
- Pharma Promotion 2026: Influencers, GenAI and Privacy.
- Generative and Agentic AI in Pharmaceutical Marketing.
- LillyDirect and Direct-to-Patient Pharma.
- Market Access Reset 2026: EU Joint Clinical Assessment and Medicare Negotiation.
- Casgevy and the CMS Outcomes-Based Access Model.
These resources show how current industry shifts affect brand strategy, evidence, channels, access and risk management. They are educational cases and do not constitute legal, regulatory or medical advice.
LEARN THROUGH SIX INTERACTIVE ROLE PLAYS
1. MLR Crisis Room: Influencers, GenAI and Privacy Under Pressure.
2. Omnichannel Launch War Room: Build PX-317 Readiness Plan.
3. US Payer Negotiation.
4. EU JCA Evidence Council.
5. AI Incident Command.
6. Global Launch Council.
In each simulation, you must analyse incomplete information, balance competing priorities, communicate with stakeholders and defend a recommendation. These activities develop professional judgement, not just recall.
COMPLETE A GLOBAL SPECIALTY LAUNCH CAPSTONE
The final capstone places you on the launch team for a fictional specialty medicine. You will integrate decisions across the United States and Europe, including:
- Market and patient-flow assumptions.
- Segmentation and positioning.
- Stakeholder and channel strategy.
- Promotional and privacy guardrails.
- Evidence and market access requirements.
- Launch sequencing and KPIs.
- Risk mitigation and cross-functional governance.
You will then defend your plan in the Global Launch Council role play. The capstone is designed to consolidate the course into a coherent, portfolio-ready strategic recommendation.
COURSE JOURNEY
The course progresses from fundamentals to advanced application:
1. Foundations of Pharmaceutical Marketing.
2. Navigating the Regulatory and Compliance Maze.
3. Crafting a Winning Pharmaceutical Marketing Strategy.
4. Mastering Digital Pharmaceutical Marketing.
5. Orchestrating Omnichannel Customer Experiences.
6. Effective HCP Engagement Strategies.
7. Championing Patient-Centricity.
8. Market Access and Value Demonstration.
9. Leveraging Data: RWE and Advanced Analytics.
10. Advanced Strategic Frameworks and Financial Acumen.
11. The Future of Pharmaceutical Marketing.
12. Global Specialty Launch Capstone.
WHAT IS INCLUDED
You receive more than nine hours of on-demand video, knowledge checks, downloadable resources, current case materials, six interactive role plays and an integrated final simulation. The course is designed so that you can follow it from beginning to end or revisit individual modules when facing a specific professional decision.
WHO THIS COURSE IS FOR
This course is designed for:
- Pharmaceutical product and brand managers.
- Commercial, sales and marketing professionals.
- Digital, omnichannel and customer-experience teams.
- Market access, HEOR and RWE professionals who collaborate with commercial teams.
- Medical affairs, regulatory and compliance professionals seeking commercial context.
- Consultants, agencies and service providers working with life-sciences clients.
- Business-development and strategy professionals.
- Graduates and career changers seeking a structured view of pharmaceutical marketing.
The course is taught in English and uses global examples with particular attention to US and European decision environments. No previous pharmaceutical marketing role is required, although familiarity with business strategy or healthcare will help.
WHAT YOU WILL BE ABLE TO DO
By the end of the course, you should be able to:
- Frame a pharmaceutical marketing problem and identify the decision that matters.
- Translate market, customer and evidence insights into a differentiated strategy.
- Design a compliant omnichannel plan with clear objectives and KPIs.
- Collaborate more effectively with medical, legal, regulatory, privacy and market access teams.
- Evaluate AI-enabled marketing ideas with appropriate governance.
- Present and defend an integrated global launch recommendation.
The goal is not to memorise isolated models. It is to build a repeatable way of thinking that can be applied to a brand plan, launch plan, customer-engagement strategy, market-access discussion or cross-functional decision.
If you want to move beyond generic marketing theory and learn how pharmaceutical strategy is developed, challenged and defended in real-world decision environments, this course provides the frameworks and practice to do it with confidence.